AUTL
Autolus Therapeutics·NASDAQ
--
--(--)
--
--(--)
AUTL Filings
Filing Date
Form Description
Form Type
2026-01-26
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-26 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-26
Form 8-K - Current report
Key Events
2026-01-26 · Key Events
Form 8-K - Current report
2026-01-12
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-12 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2025-12-03
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-03 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-02
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-02 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-02
Form 8-K - Current report
Key Events
2025-12-02 · Key Events
Form 8-K - Current report
2025-11-18
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2025-11-18 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
